Metabolic syndrome laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
'''1)''' [[Thyroid function test]] | '''1)''' [[Thyroid function test]] | ||
'''2)''' [[Liver function test]] ([[Fatty liver]] especially in concurrent [[obesity]] | '''2)''' [[Liver function test]] ([[Fatty liver]] especially in concurrent [[obesity]], progressing to [[non-alcoholic fatty liver disease]]) | ||
'''3)''' Serum [[uric acid]] (elevated uric acids) | '''3)''' Serum [[uric acid]] (elevated uric acids) | ||
Revision as of 16:37, 28 September 2011
|
Metabolic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic syndrome laboratory findings On the Web |
|
American Roentgen Ray Society Images of Metabolic syndrome laboratory findings |
|
Risk calculators and risk factors for Metabolic syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
The diagnosis of metabolic syndrome is mostly based on physical examination and lab tests. The diagnostic criteria of different international societies also involves consideration of lab tests like lipid profile and fasting blood glucose.
Laboratory studies
1) Blood glucose (fasting, post-prandial) and HbA1C (diabetes)
2) Urine tests (renal dysfunction)
3) Lipid profile (hypertriglyceridemia or low HDL levels)
4) Additional tests like apolipoprotein-B100, high-sensitivity CRP (C-reactive protein homocysteine and fractionated LDL should be done in high risk patients with family history.
Other tests may include
2) Liver function test (Fatty liver especially in concurrent obesity, progressing to non-alcoholic fatty liver disease)
3) Serum uric acid (elevated uric acids)